Pulmonary vascular disease, environmental pollution, and climate change

Documenti analoghi

• Reassessment of the Current Iron Deficiency Definition in Pulmonary Hypertension
  di: Aurelia E. Reiser, et al.
  Pubblicazione: (2025)
• Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative—Group 3 Pulmonary Hypertension
  di: Oksana A. Shlobin, et al.
  Pubblicazione: (2024)
• Cardiopulmonary Exercise Testing With Simultaneous Echocardiography After Pulmonary Embolism
  di: Karys Khilzi, et al.
  Pubblicazione: (2025)
• The European Voice of the Patient living with pulmonary hypertension associated with interstitial lung disease: Diagnosis, symptoms, impacts, and treatments
  di: Lucilla Piccari, et al.
  Pubblicazione: (2024)
• Screening and diagnosis of pulmonary hypertension associated with chronic lung disease (PH‐CLD): A consensus statement from the pulmonary vascular research institute's innovative drug development initiative—group 3 pulmonary hypertension
  di: P. Vitulo, et al.
  Pubblicazione: (2024)